RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Perspectives of rural development and the role of agricultural lending in Albania
2009-01-01 Belletti, Matteo; Leksinaj, E.; Petrocchi, Roberto; Meco, M.; Mussabelliu, B.
Perspectives of the prediction of pesticide environmental concentrations and related questions
2001-01-01 M., Trevisan; L., Padovani; Vischetti, Costantino; E., Capri
Perspectives on endocrine disruptor effects on metabolic sensors
2011-01-01 Migliarini, B.; Piccinetti, C. C.; Martella, A.; Maradonna, Francesca; Gioacchini, Giorgia; Carnevali, Oliana
Perspectives on mild cognitive impairment as a precursor of Alzheimer's disease
2020-01-01 Fiorini, Rosamaria; Luzzi, Simona; Vignini, Arianna
Perturbation analysis for dynamic poverty indexes
2023-01-01 D’Amico, Guglielmo; De Blasis, Riccardo; Gismondi, Fulvio
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome
2021-01-01 Tovy, Ayala; Rosas, Carina; Gaikwad, Amos S; Medrano, Geraldo; Zhang, Linda; Reyes, Jaime M; Huang, Yung-Hsin; Arakawa, Tastuhiko; Kurtz, Kristen; Conneely, Shannon E; Guzman, Anna G; Aguilar, Rogelio; Gao, Anne; Chen, Chun-Wei; Kim, Jean J; Carter, Melissa T; Lasa-Aranzasti, Amaia; Valenzuela, Irene; Van Maldergem, Lionel; Brunetti, Lorenzo; Hicks, M John; Marcogliese, Andrea N; Goodell, Margaret A; Rau, Rachel E
Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction
2013-01-01 Rimessi, Alessandro; Bonora, Massimo; Marchi, Saverio; Patergnani, Simone; Marobbio, Carlo M. T.; Lasorsa, Francesco M; Pinton, Paolo
Perturbing two-dimensional maps having critical homoclinic orbits
1999-01-01 Battelli, Flaviano; Lazzari, C.
Pesco, meno lavoro d’inverno se prima si fa la potatura verde
2011-01-01 Neri, Davide
Pesco, OK alla potatura verde.
2010-01-01 Neri, Davide
Pesticide adsorption and degradation in fine earth and rock fragments of two soils of different origin
2010-01-01 Vischetti, Costantino; Corti, Giuseppe; Monaci, Elga; Cocco, Stefania; Coppola, L; Agnelli, A.
Pesticides in drinking water: analysis of a lake scenario with a mathematical model
2000-01-01 Vischetti, Costantino; C., Marucchini; A., Esposito; C., Zadra
PET study in subjects from two Italian FAD families with APP717 val to ileu matation
1997-01-01 D., Perani; F., Grassi; S., Sorbi; S., Nacmias; Provinciali, Leandro; L., Amaducci; F., Fazio
Petals and thorns in programmed death-ligand 1 testing: Is all non–small cell lung cancer diagnostic material suitable?
2018-01-01 Bravaccini, S.; Bronte, G.
Peter J. Fensham
2018-01-01 Cardellini, L.
Peterhouse. Prove di modernità in un college di Cambridge
2018-01-01 Alici, Antonello
Petrosia ficiformis (Poiret, 1789): an excellent model for holobiont and biotechnological studies
2022-01-01 Cerrano, C.; Giovine, M.; Steindler, L.
PFOA effects on osteoblast differentiation: Involvement of oxidative stress and endocannabinoid receptors
2026-01-01 Sella, Fiorenza; Giommi, Christian; Carbonari, Damiano; Lombó, Marta; Carnevali, Oliana
PGR5 and NDH-1 systems do not function as protective electron acceptors but mitigate the consequences of PSI inhibition
2020-01-01 Rantala, S.; Lempiainen, T.; Gerotto, C.; Tiwari, A.; Aro, E. -M.; Tikkanen, M.
pH+ Architects – Pinnacle N10, Londra, Regno Unito
2018-01-01 DI GIUSEPPE, Elisa
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer
2018-01-01 Bartolacci, Caterina; Andreani, Cristina; Curcio, Claudia; Occhipinti, Sergio; Massaccesi, Luca; Giovarelli, Mirella; Galeazzi, Roberta; Iezzi, Manuela; Tilio, Martina; Gambini, Valentina; Wang, Junbiao; Marchini, Cristina; Amici, Augusto
Phages and enzybiotics in food biopreservation
2021-01-01 Ramos-Vivas, J.; Elexpuru-Zabaleta, M.; Samano, M. L.; Barrera, A. P.; Forbes-Hernandez, T. Y.; Giampieri, F.; Battino, M.
Phanerozoic Organic-Carbon-Rich Marine Sediments: Overview and Future Research Challenges
2009-01-01 Negri, Alessandra; A., Ferretti; T., Wagner; P. A., Meyers
Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management
2010-01-01 Osimani, Barbara
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease
1997-01-01 Senin, Umberto; Cherubini, Antonio; Palumbo, Barbara; Mecocci, Patrizia
Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms
2018-01-01 Mezzelani, Marica; Gorbi, Stefania; Regoli, Francesco
Pharmaco-EEG in psychiatry
2006-01-01 Mucci, Armida; Volpe, Umberto; Merlotti, Eleonora; Bucci, Paola; Galderisi, Silvana
Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats
2018-01-01 Carlier, J.; Wohlfarth, A.; Salmeron, B. D.; Scheidweiler, K. B.; Huestis, M. A.; Baumann, M. H.
Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice
2020-01-01 Verrotti, A.; Lattanzi, S.; Brigo, F.; Zaccara, G.
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis
2019-01-01 Campanati, A; Paolinelli, M; Diotallevi, F; Martina, E; Molinelli, E; Offidani, A.
Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy
2006-01-01 Ruzzo, A; Graziano, F; Kawakami, K; Watanabe, G; Santini, D; Catalano, V; Bisonni, R; Canestrari, E; Ficarelli, R; Menichetti, Et; Mari, D; Testa, E; Silva, R; Vincenzi, B; Giordani, P; Cascinu, Stefano; Giustini, L; Tonini, G; Magnani, M.
Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock
2023-01-01 Scorcella, C.; Domizi, R.; Amoroso, S.; Carsetti, A.; Casarotta, E.; Castaldo, P.; D’Angelo, C.; Damiani, E.; Gasparri, F.; Donati, A.; Adrario, E.
Pharmacogenomics of cetuximab in metastatic colorectal carcinoma
2014-01-01 Silvestris, Nicola; Vincenzi, Bruno; Brunetti, Anna Elisabetta; Loupakis, Fotious; Dell'Aquila, Emanuela; Russo, Antonio; Scartozzi, Mario; Giampieri, Riccardo; Cascinu, Stefano; Lorusso, Vito; Tonini, Giuseppe; Falcone, Alfredo; Santini, Daniele
Pharmacokinetic and Dynamic of Amlodipine in Comparison with Nifedipine AR in Patients with Mild to Moderate Hypertension
1991-01-01 Bompadre, Stefano; C., Bedetta; P., Capone; M. L., Cingolani; Ferrante, Luigi; Leone, Luciana; S., Ripa
Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overview
2022-01-01 D'Onofrio, Gianluca; Riva, Antonella; Amadori, Elisabetta; Lattanzi, Simona; Rose, Klaus; Verrotti, Alberto; Striano, Pasquale
Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy
2021-01-01 Zaccara, Gaetano; Lattanzi, Simona; Russo, Emilio
Pharmacokinetic profile and endocrine effects of posatirelin treatment in healthy elderly subjects
1996-01-01 Reboldi, Gianpaolo; Parnetti, Lucilla; Santeusanio, Fausto; Ambrosoli, L; Palumbo, Barbara; Cherubini, Antonio; Girardello, R; Poli, A; Lowenthal, Dt; Senin, Umberto
Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome.
2011-01-01 Cogo, Pe; Facco, M; Simonato, M; De Luca, D; De Terlizi, F; Rizzotti, U; Verlato, G; Bellagamba, Mp; Carnielli, Virgilio
Pharmacokinetics of Bacampicillin Using a Compartment Model with Zero-Order Absorption.
1988-01-01 S., Ripa; Ferrante, Luigi; F., Mignini; U., Ecari; M. P., Ruffilli
Pharmacokinetics of Fluconazole in Normal Volunteers.
1993-01-01 S., Ripa; Ferrante, Luigi; M., Prenna
Pharmacokinetics of Sulbactam/Ampicillin in Humans after Intravenous and Intramuscular Injection
1990-01-01 S., Ripa; Ferrante, Luigi; M., Prenna
Pharmacokinetics of Teicoplanin
1988-01-01 S., Ripa; Ferrante, Luigi; F., Mignini; E., Falcioni
Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
1997-01-01 Olivieri, Attilio; Poloni, Antonella; Montanari, M; Cantori, I; Corvatta, L; Masia, Mc; Curzi, L; Mancini, Stefania; Leoni, Pietro
Pharmacologic management of Cushing's syndrome
2005-01-01 N., Sonino; Boscaro, Marco; F., Fallo
Pharmacological activation of Nrf2: Cardioprotective effects of statins and metformin against dyslipidemia-induced oxidative stress
2025-01-01 Mthembu, Sinenhlanhla X. H.; Mazibuko-Mbeje, Sithandiwe E.; Ziqubu, Khanyisani; Silvestri, Sonia; Orlando, Patrick; Nkambule, Bongani B.; Muller, Christo J. F.; Tiano, Luca; Dludla, Phiwayinkosi V.
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice
2020-01-01 Giulietti, F.; Filipponi, A.; Rosettani, G.; Giordano, P.; Iacoacci, C.; Spannella, F.; Sarzani, R.
Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells
2000-01-01 Triggiani, M; Gentile, M; Secondo, Agnese; Granata, F; Oriente, A; Taglialatela, M; Annunziato, L; Marone, G.
Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells
2000-01-01 Secondo, Agnese; Taglialatela, M; Cataldi, Mauro; Giorgio, G; Valore, M; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, L.
Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells
2000-01-01 Secondo, Agnese; Taglialatela, Maurizio; Cataldi, Mauro; Giorgio, G; Valore, M; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, Lucio
Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH3 cells
2000-01-01 Secondo, Agnese; Taglialatela, Maurizio; Cataldi, Mauro; Giorgio, G.; Valore, M.; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, L.
pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary gh3 cells
2000-01-01 Secondo, Agnese; Taglialatela, M.; Cataldi, Mauro; Giorgio, G.; Valore, M.; DI RENZO, GIANFRANCO MARIA LUIGI; AND ANNUNZIATO, L.
Pharmacological characterization of the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) as a potent NCX3 inhibitor that worsens anoxic injury in cortical neurons, organotypic hippocampal cultures, and ischemic brain
2015-01-01 Secondo, Agnese; Pignataro, Giuseppe; Ambrosino, Paolo; Pannaccione, Anna; Molinaro, Pasquale; Boscia, Francesca; Cantile, Maria; Cuomo, Ornella; Esposito, Alba; Sisalli, MARIA JOSE'; Scorziello, Antonella; Guida, Natascia; Anzilotti, Serenella; Fiorino, Ferdinando; Severino, Beatrice; Santagada, Vincenzo; Caliendo, Giuseppe; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, Lucio
Pharmacological effects of methylone and MDMA in humans
2023-01-01 Poyatos, Lourdes; Pérez-Mañá, Clara; Hladun, Olga; Núñez-Montero, Melani; De La Rosa, Georgina; Martín, Soraya; Barriocanal, Ana Maria; Carabias, Lydia; Kelmendi, Benjamin; Taoussi, Omayema; Busardo', Francesco Paolo; Fonseca, Francina; Torrens, Marta; Pichini, Simona; Farré, Magí; Papaseit, Esther
Pharmacological evidence that the activation of the Na+-Ca2+ exchanger protects C6 glioma cells during chemical hypoxya.
1997-01-01 Amoroso, Salvatore; DE MAIO, M.; Russo, G. M.; Catalano, A.; Bassi, A.; Montagnani, S.; DI RENZO, G. F.; Annunziato, L.
Pharmacological inhibition of lysosomal two-pore channel 2 (TPC2) confers neuroprotection in stroke via autophagy regulation
2023-01-01 Tedeschi, Valentina; Vinciguerra, Antonio; José Sisalli, Maria; Pignataro, Giuseppe; Secondo, Agnese
Pharmacological inhibition of the Na+-Ca2+ exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory aminoacids in striatal neurons.
1999-01-01 Calabresi, P.; Marfia, G. A.; Amoroso, Salvatore; Pisani, A.; Bernardi, G.
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry
2021-01-01 Ciliberti, G.; Verdoia, M.; Merlo, M.; Zilio, F.; Vatrano, M.; Mancone, M.; Zaffalon, D.; Bonci, A.; Boscutti, A.; Infusino, F.; Coiro, S.; Stronati, G.; Tritto, I.; Gioscia, R.; Dello Russo, A.; Fedele, F.; Gallina, S.; Cassadonte, F.; Ambrosio, G.; Bonmassari, R.; De Luca, G.; Sinagra, G.; Capucci, A.; Kaski, J. C.; Guerra, F.; Bianco, F.
Pharmacological treatment of fibromyalgia
2010-01-01 Di Franco, M; Iannuccelli, C; Atzeni, F; Cazzola, M; Salaffi, Fausto; Valesini, G; Sarzi Puttini, P.
Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies
2020-01-01 Pistollato, F.; Forbes-Hernandez, T. Y.; Calderon Iglesias, R.; Ruiz, R.; Elexpuru Zabaleta, M.; Cianciosi, D.; Giampieri, F.; Battino, M.
Pharmacology and legal status of cannabidiol
2020-01-01 Brunetti, P.; Lo Faro, A. F.; Pirani, F.; Berretta, P.; Pacifici, R.; Pichini, S.; Busardo, F. P.
Pharmacology and toxicology of xylazine: quid novum?
2023-01-01 Malaca, Sara; Pesaresi, M; Kapoor, A; Berretta, P; Busardo, F P; Pirani, F
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability
2021-01-01 Roberti, R.; De Caro, C.; Iannone, L. F.; Zaccara, G.; Lattanzi, S.; Russo, E.
Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects
2020-01-01 Brunetti, P.; Lo Faro, A. F.; Tini, A.; Busardo, F. P.; Carlier, J.
Pharmacotherapeutic considerations for late-onset epilepsy
2020-01-01 Brigo, Francesco; Lattanzi, Simona
Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
2023-01-01 Lattanzi, Simona; Trinka, Eugen; Russo, Emilio; Del Giovane, Cinzia; Matricardi, Sara; Meletti, Stefano; Striano, Pasquale; Damavandi, Payam Tabaee; Silvestrini, Mauro; Brigo, Francesco
Pharmacotoxicology of non-fentanyl derived new synthetic opioids
2018-01-01 Solimini, R.; Pichini, S.; Pacifici, R.; Busardò, F. P.; Giorgetti, R.
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
2024-01-01 Richard J, Auchus; Oksana, Hamidi; Rosario, Pivonello; Irina, Bancos; Gianni, Russo; Selma F, Witchel; Andrea M, Isidori; Patrice, Rodien; Umasuthan, Srirangalingam; Florian W, Kiefer; Henrik, Falhammar; Deborah P, Merke; Nicole, Reisch; Kyriakie, Sarafoglou; Gordon B, Cutler; Julia, Sturgeon; Eiry, Roberts; Vivian H, Lin; Jean L, Chan; Robert H., Farber; Adult Trial Investigators, Cahtalyst; Giacchetti, Gilberta
Phase and Orientational Behaviors in Liquid Crystalline Main-Chain/Side-Group Block Copolymers
1998-01-01 D., Ferri; D., Wolff; J., Springer; Francescangeli, Oriano; M., Laus; A. S., Angeloni; G., Galli; E., Chiellini
Phase and Thermal Behavior of Liquid-Crystalline Block Copolymers
1996-01-01 D., Wolff; D., Ferri; J., Springer; Francescangeli, Oriano; M., Laus; A. S., Angeloni; C., Bignozzi; G., Galli; E., Chiellini
Phase behavior and structural characterization of poly(1,3-propylene adipate)s with cyanoazobenzene side groups
1998-01-01 E. L., Tassi; M., Paci; P. L., Magagnini; B., Yang; Francescangeli, Oriano; F., Rustichelli
Phase change Ge-rich Ge–Sb–Te/Sb2Te3 core-shell nanowires by metal organic chemical vapor deposition
2021-01-01 Kumar, A.; Cecchini, R.; Wiemer, C.; Mussi, V.; De Simone, S.; Calarco, R.; Scuderi, M.; Nicotra, G.; Longo, M.
Phase characterization of ion-beam mixed and thermally reacted Fe/Pd thin film bilayer
1990-01-01 G., Battaglin; G., Fagherazzi; S., Polizzi; G., Majni; Mengucci, Paolo
Phase Composition of Al-Si Coating from the Initial State to the Hot-Stamped Condition
2021-01-01 Kucera, V.; Cabibbo, M.; Prusa, F.; Fojt, J.; Petr-Soini, J.; Pilvousek, T.; Kolarikova, M.; Vojtech., D.
Phase contrast microtomography of thin biomaterials
2004-01-01 S., Romanzetti; E., Girardin; Rustichelli, Franco; B., Dubini; A., Snigirev; C., Raven; G., Rizzi
Phase control of escapes in the fractional damped Helmholtz oscillator
2024-01-01 Coccolo, Mattia; Seoane, Jesús M.; Lenci, Stefano; Sanjuán, Miguel A. F.
Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies.
2009-01-01 Zanardi, S.; Puntoni, M.; Maffezzini, M.; Bandelloni, R.; Mori, M.; Argusti, A.; Campodonico, F.; Turbino, L.; Branchi, D.; Montironi, Rodolfo; Decensi, A.
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours
2013-01-01 G., Spitaleri; Berardi, Rossana; C., Pierantoni; T., De Pas; C., Noberasco; C., Libbra; R. González Iglesias L., Giovannoni; A., Tasciotti; D., Neri; H. D., Menssen; F., de Braud
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment
2012-01-01 Mancuso, A; Di Paola, Ed; Leone, A; Catalano, Alfonso; Calabrò, F; Cerbone, L; Zivi, A; Messina, C; Alonso, S; Vigna, L; Caristo, R; Sternberg, C. N.
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study).
2009-01-01 C., Pinto; F. D., Fabio; C., Barone; S., Siena; A., Falcone; Cascinu, Stefano; F. L., Rojas; G., Stella; G., Schinzari; S., Artale; V., Mutri; S., Giaquinta; L., Giannetta; A., Bardelli; A. A., Martoni
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).
2007-01-01 Pinto, C; DI FABIO, F; Siena, S; Cascinu, Stefano; ROJAS LLIMPE, F; Ceccarelli, C; Mutri, V; Giannetta, L; Giaquinta, S; Funaioli, C; Berardi, Rossana; Longobardi, C; Piana, E; Martoni, A.
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
2021-01-01 Pellegrino, B.; Cavanna, L.; Boggiani, D.; Zamagni, C.; Frassoldati, A.; Schirone, A.; Caldara, A.; Rocca, A.; Gori, S.; Piacentini, F.; Berardi, R.; Brandes, A. A.; Foglietta, J.; Villa, F.; Todeschini, R.; Tognetto, M.; Naldi, N.; Bortesi, B.; Montemurro, F.; Ardizzoni, A.; Boni, L.; Musolino, A.
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma
2012-01-01 Offidani, M; Polloni, C; Cavallo, F; Marina Liberati, A; Ballanti, S; Pulini, S; Catarini, M; Alesiani, F; Corvatta, L; Gentili, S; Caraffa, P; Boccadoro, M; Leoni, Pietro; Palumbo, A.
Phase II study of paclitaxel in pretreated advanced gastric cancer.
1998-01-01 Cascinu, Stefano; F., Graziano; N., Cardarelli; M., Marcellini; P., Giordani; E. T., Menichetti; G., Catalano
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients.
2012-01-01 M., Scartozzi; Loretelli, Cristian; Berardi, Rossana; C., Pierantoni; R. R., Silva; D., Mari; Giampieri, Riccardo; Faloppi, Luca; M., Pistelli; Maccaroni, Elena; Bittoni, Alessandro; M. D., Prete; E., Galizia; Cascinu, Stefano
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.
2010-01-01 F., Loupakis; G., Masi; L., Fornaro; E., Vasile; G., Allegrini; E., Fontana; C., Granetto; L., Salvatore; L., Mentuccia; M., Andreuccetti; E., Cortesi; M., Merlano; Cascinu, Stefano; A., Falcone
Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
1996-01-01 Cascinu, Stefano; E. D., Ferro; M., Ligi; F., Graziano; A., Castellani; G., Catalano
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
2007-01-01 Guarneri, V; Frassoldati, A; Ficarra, G; Puglisi, F; Andreetta, C; Michelotti, A; Cresti, N; Boni, C; Bisagni, G; Berardi, Rossana; Battelli, N; Santoro, A; Banna, G; Bottini, A; Blasio, Bd; Maiorana, A; Piacentini, F; Giovannelli, S; Jovic, G; Conte, P.
Phase III dose-comparison study of Glatiramer Acetate for Multiple Sclerosis
2011-01-01 Comi, G; Cohen, Jl; Arnodl, Dl; Provinciali, Leandro; On the FORTE Study Group, . . .
Phase mapping of acoustic sources by beamforming and iterative far field monopole substitution
2012-01-01 Castellini, P.; Sopranzetti, Francesca
Phase only modulation by Polymer Dispersed Liquid Crystals
2002-01-01 Lucchetta, Daniele Eugenio; R., Karapinar; A. MANNI AND F., Simoni
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Perspectives of rural development and the role of agricultural lending in Albania | 1-gen-2009 | Belletti, Matteo; Leksinaj, E.; Petrocchi, Roberto; Meco, M.; Mussabelliu, B. | |
| Perspectives of the prediction of pesticide environmental concentrations and related questions | 1-gen-2001 | M., Trevisan; L., Padovani; Vischetti, Costantino; E., Capri | |
| Perspectives on endocrine disruptor effects on metabolic sensors | 1-gen-2011 | Migliarini, B.; Piccinetti, C. C.; Martella, A.; Maradonna, Francesca; Gioacchini, Giorgia; Carnevali, Oliana | |
| Perspectives on mild cognitive impairment as a precursor of Alzheimer's disease | 1-gen-2020 | Fiorini, Rosamaria; Luzzi, Simona; Vignini, Arianna | |
| Perturbation analysis for dynamic poverty indexes | 1-gen-2023 | D’Amico, Guglielmo; De Blasis, Riccardo; Gismondi, Fulvio | |
| Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome | 1-gen-2021 | Tovy, Ayala; Rosas, Carina; Gaikwad, Amos S; Medrano, Geraldo; Zhang, Linda; Reyes, Jaime M; Huang, Yung-Hsin; Arakawa, Tastuhiko; Kurtz, Kristen; Conneely, Shannon E; Guzman, Anna G; Aguilar, Rogelio; Gao, Anne; Chen, Chun-Wei; Kim, Jean J; Carter, Melissa T; Lasa-Aranzasti, Amaia; Valenzuela, Irene; Van Maldergem, Lionel; Brunetti, Lorenzo; Hicks, M John; Marcogliese, Andrea N; Goodell, Margaret A; Rau, Rachel E | |
| Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction | 1-gen-2013 | Rimessi, Alessandro; Bonora, Massimo; Marchi, Saverio; Patergnani, Simone; Marobbio, Carlo M. T.; Lasorsa, Francesco M; Pinton, Paolo | |
| Perturbing two-dimensional maps having critical homoclinic orbits | 1-gen-1999 | Battelli, Flaviano; Lazzari, C. | |
| Pesco, meno lavoro d’inverno se prima si fa la potatura verde | 1-gen-2011 | Neri, Davide | |
| Pesco, OK alla potatura verde. | 1-gen-2010 | Neri, Davide | |
| Pesticide adsorption and degradation in fine earth and rock fragments of two soils of different origin | 1-gen-2010 | Vischetti, Costantino; Corti, Giuseppe; Monaci, Elga; Cocco, Stefania; Coppola, L; Agnelli, A. | |
| Pesticides in drinking water: analysis of a lake scenario with a mathematical model | 1-gen-2000 | Vischetti, Costantino; C., Marucchini; A., Esposito; C., Zadra | |
| PET study in subjects from two Italian FAD families with APP717 val to ileu matation | 1-gen-1997 | D., Perani; F., Grassi; S., Sorbi; S., Nacmias; Provinciali, Leandro; L., Amaducci; F., Fazio | |
| Petals and thorns in programmed death-ligand 1 testing: Is all non–small cell lung cancer diagnostic material suitable? | 1-gen-2018 | Bravaccini, S.; Bronte, G. | |
| Peter J. Fensham | 1-gen-2018 | Cardellini, L. | |
| Peterhouse. Prove di modernità in un college di Cambridge | 1-gen-2018 | Alici, Antonello | |
| Petrosia ficiformis (Poiret, 1789): an excellent model for holobiont and biotechnological studies | 1-gen-2022 | Cerrano, C.; Giovine, M.; Steindler, L. | |
| PFOA effects on osteoblast differentiation: Involvement of oxidative stress and endocannabinoid receptors | 1-gen-2026 | Sella, Fiorenza; Giommi, Christian; Carbonari, Damiano; Lombó, Marta; Carnevali, Oliana | |
| PGR5 and NDH-1 systems do not function as protective electron acceptors but mitigate the consequences of PSI inhibition | 1-gen-2020 | Rantala, S.; Lempiainen, T.; Gerotto, C.; Tiwari, A.; Aro, E. -M.; Tikkanen, M. | |
| pH+ Architects – Pinnacle N10, Londra, Regno Unito | 1-gen-2018 | DI GIUSEPPE, Elisa | |
| Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer | 1-gen-2018 | Bartolacci, Caterina; Andreani, Cristina; Curcio, Claudia; Occhipinti, Sergio; Massaccesi, Luca; Giovarelli, Mirella; Galeazzi, Roberta; Iezzi, Manuela; Tilio, Martina; Gambini, Valentina; Wang, Junbiao; Marchini, Cristina; Amici, Augusto | |
| Phages and enzybiotics in food biopreservation | 1-gen-2021 | Ramos-Vivas, J.; Elexpuru-Zabaleta, M.; Samano, M. L.; Barrera, A. P.; Forbes-Hernandez, T. Y.; Giampieri, F.; Battino, M. | |
| Phanerozoic Organic-Carbon-Rich Marine Sediments: Overview and Future Research Challenges | 1-gen-2009 | Negri, Alessandra; A., Ferretti; T., Wagner; P. A., Meyers | |
| Pharmaceutical risk communication: Sources of uncertainty and legal tools of uncertainty management | 1-gen-2010 | Osimani, Barbara | |
| Pharmaceutical treatment of cognitive disorders in Alzheimer's disease | 1-gen-1997 | Senin, Umberto; Cherubini, Antonio; Palumbo, Barbara; Mecocci, Patrizia | |
| Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms | 1-gen-2018 | Mezzelani, Marica; Gorbi, Stefania; Regoli, Francesco | |
| Pharmaco-EEG in psychiatry | 1-gen-2006 | Mucci, Armida; Volpe, Umberto; Merlotti, Eleonora; Bucci, Paola; Galderisi, Silvana | |
| Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats | 1-gen-2018 | Carlier, J.; Wohlfarth, A.; Salmeron, B. D.; Scheidweiler, K. B.; Huestis, M. A.; Baumann, M. H. | |
| Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice | 1-gen-2020 | Verrotti, A.; Lattanzi, S.; Brigo, F.; Zaccara, G. | |
| Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis | 1-gen-2019 | Campanati, A; Paolinelli, M; Diotallevi, F; Martina, E; Molinelli, E; Offidani, A. | |
| Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy | 1-gen-2006 | Ruzzo, A; Graziano, F; Kawakami, K; Watanabe, G; Santini, D; Catalano, V; Bisonni, R; Canestrari, E; Ficarelli, R; Menichetti, Et; Mari, D; Testa, E; Silva, R; Vincenzi, B; Giordani, P; Cascinu, Stefano; Giustini, L; Tonini, G; Magnani, M. | |
| Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock | 1-gen-2023 | Scorcella, C.; Domizi, R.; Amoroso, S.; Carsetti, A.; Casarotta, E.; Castaldo, P.; D’Angelo, C.; Damiani, E.; Gasparri, F.; Donati, A.; Adrario, E. | |
| Pharmacogenomics of cetuximab in metastatic colorectal carcinoma | 1-gen-2014 | Silvestris, Nicola; Vincenzi, Bruno; Brunetti, Anna Elisabetta; Loupakis, Fotious; Dell'Aquila, Emanuela; Russo, Antonio; Scartozzi, Mario; Giampieri, Riccardo; Cascinu, Stefano; Lorusso, Vito; Tonini, Giuseppe; Falcone, Alfredo; Santini, Daniele | |
| Pharmacokinetic and Dynamic of Amlodipine in Comparison with Nifedipine AR in Patients with Mild to Moderate Hypertension | 1-gen-1991 | Bompadre, Stefano; C., Bedetta; P., Capone; M. L., Cingolani; Ferrante, Luigi; Leone, Luciana; S., Ripa | |
| Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overview | 1-gen-2022 | D'Onofrio, Gianluca; Riva, Antonella; Amadori, Elisabetta; Lattanzi, Simona; Rose, Klaus; Verrotti, Alberto; Striano, Pasquale | |
| Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy | 1-gen-2021 | Zaccara, Gaetano; Lattanzi, Simona; Russo, Emilio | |
| Pharmacokinetic profile and endocrine effects of posatirelin treatment in healthy elderly subjects | 1-gen-1996 | Reboldi, Gianpaolo; Parnetti, Lucilla; Santeusanio, Fausto; Ambrosoli, L; Palumbo, Barbara; Cherubini, Antonio; Girardello, R; Poli, A; Lowenthal, Dt; Senin, Umberto | |
| Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome. | 1-gen-2011 | Cogo, Pe; Facco, M; Simonato, M; De Luca, D; De Terlizi, F; Rizzotti, U; Verlato, G; Bellagamba, Mp; Carnielli, Virgilio | |
| Pharmacokinetics of Bacampicillin Using a Compartment Model with Zero-Order Absorption. | 1-gen-1988 | S., Ripa; Ferrante, Luigi; F., Mignini; U., Ecari; M. P., Ruffilli | |
| Pharmacokinetics of Fluconazole in Normal Volunteers. | 1-gen-1993 | S., Ripa; Ferrante, Luigi; M., Prenna | |
| Pharmacokinetics of Sulbactam/Ampicillin in Humans after Intravenous and Intramuscular Injection | 1-gen-1990 | S., Ripa; Ferrante, Luigi; M., Prenna | |
| Pharmacokinetics of Teicoplanin | 1-gen-1988 | S., Ripa; Ferrante, Luigi; F., Mignini; E., Falcioni | |
| Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide. | 1-gen-1997 | Olivieri, Attilio; Poloni, Antonella; Montanari, M; Cantori, I; Corvatta, L; Masia, Mc; Curzi, L; Mancini, Stefania; Leoni, Pietro | |
| Pharmacologic management of Cushing's syndrome | 1-gen-2005 | N., Sonino; Boscaro, Marco; F., Fallo | |
| Pharmacological activation of Nrf2: Cardioprotective effects of statins and metformin against dyslipidemia-induced oxidative stress | 1-gen-2025 | Mthembu, Sinenhlanhla X. H.; Mazibuko-Mbeje, Sithandiwe E.; Ziqubu, Khanyisani; Silvestri, Sonia; Orlando, Patrick; Nkambule, Bongani B.; Muller, Christo J. F.; Tiano, Luca; Dludla, Phiwayinkosi V. | |
| Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice | 1-gen-2020 | Giulietti, F.; Filipponi, A.; Rosettani, G.; Giordano, P.; Iacoacci, C.; Spannella, F.; Sarzani, R. | |
| Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells | 1-gen-2000 | Triggiani, M; Gentile, M; Secondo, Agnese; Granata, F; Oriente, A; Taglialatela, M; Annunziato, L; Marone, G. | |
| Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells | 1-gen-2000 | Secondo, Agnese; Taglialatela, M; Cataldi, Mauro; Giorgio, G; Valore, M; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, L. | |
| Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells | 1-gen-2000 | Secondo, Agnese; Taglialatela, Maurizio; Cataldi, Mauro; Giorgio, G; Valore, M; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, Lucio | |
| Pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary GH3 cells | 1-gen-2000 | Secondo, Agnese; Taglialatela, Maurizio; Cataldi, Mauro; Giorgio, G.; Valore, M.; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, L. | |
| pharmacological blockade of ERG K+ channels and Ca2+ influx through store-operated channels exerts opposite effects on intracellular Ca2+ oscillations in pituitary gh3 cells | 1-gen-2000 | Secondo, Agnese; Taglialatela, M.; Cataldi, Mauro; Giorgio, G.; Valore, M.; DI RENZO, GIANFRANCO MARIA LUIGI; AND ANNUNZIATO, L. | |
| Pharmacological characterization of the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) as a potent NCX3 inhibitor that worsens anoxic injury in cortical neurons, organotypic hippocampal cultures, and ischemic brain | 1-gen-2015 | Secondo, Agnese; Pignataro, Giuseppe; Ambrosino, Paolo; Pannaccione, Anna; Molinaro, Pasquale; Boscia, Francesca; Cantile, Maria; Cuomo, Ornella; Esposito, Alba; Sisalli, MARIA JOSE'; Scorziello, Antonella; Guida, Natascia; Anzilotti, Serenella; Fiorino, Ferdinando; Severino, Beatrice; Santagada, Vincenzo; Caliendo, Giuseppe; DI RENZO, GIANFRANCO MARIA LUIGI; Annunziato, Lucio | |
| Pharmacological effects of methylone and MDMA in humans | 1-gen-2023 | Poyatos, Lourdes; Pérez-Mañá, Clara; Hladun, Olga; Núñez-Montero, Melani; De La Rosa, Georgina; Martín, Soraya; Barriocanal, Ana Maria; Carabias, Lydia; Kelmendi, Benjamin; Taoussi, Omayema; Busardo', Francesco Paolo; Fonseca, Francina; Torrens, Marta; Pichini, Simona; Farré, Magí; Papaseit, Esther | |
| Pharmacological evidence that the activation of the Na+-Ca2+ exchanger protects C6 glioma cells during chemical hypoxya. | 1-gen-1997 | Amoroso, Salvatore; DE MAIO, M.; Russo, G. M.; Catalano, A.; Bassi, A.; Montagnani, S.; DI RENZO, G. F.; Annunziato, L. | |
| Pharmacological inhibition of lysosomal two-pore channel 2 (TPC2) confers neuroprotection in stroke via autophagy regulation | 1-gen-2023 | Tedeschi, Valentina; Vinciguerra, Antonio; José Sisalli, Maria; Pignataro, Giuseppe; Secondo, Agnese | |
| Pharmacological inhibition of the Na+-Ca2+ exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory aminoacids in striatal neurons. | 1-gen-1999 | Calabresi, P.; Marfia, G. A.; Amoroso, Salvatore; Pisani, A.; Bernardi, G. | |
| Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry | 1-gen-2021 | Ciliberti, G.; Verdoia, M.; Merlo, M.; Zilio, F.; Vatrano, M.; Mancone, M.; Zaffalon, D.; Bonci, A.; Boscutti, A.; Infusino, F.; Coiro, S.; Stronati, G.; Tritto, I.; Gioscia, R.; Dello Russo, A.; Fedele, F.; Gallina, S.; Cassadonte, F.; Ambrosio, G.; Bonmassari, R.; De Luca, G.; Sinagra, G.; Capucci, A.; Kaski, J. C.; Guerra, F.; Bianco, F. | |
| Pharmacological treatment of fibromyalgia | 1-gen-2010 | Di Franco, M; Iannuccelli, C; Atzeni, F; Cazzola, M; Salaffi, Fausto; Valesini, G; Sarzi Puttini, P. | |
| Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies | 1-gen-2020 | Pistollato, F.; Forbes-Hernandez, T. Y.; Calderon Iglesias, R.; Ruiz, R.; Elexpuru Zabaleta, M.; Cianciosi, D.; Giampieri, F.; Battino, M. | |
| Pharmacology and legal status of cannabidiol | 1-gen-2020 | Brunetti, P.; Lo Faro, A. F.; Pirani, F.; Berretta, P.; Pacifici, R.; Pichini, S.; Busardo, F. P. | |
| Pharmacology and toxicology of xylazine: quid novum? | 1-gen-2023 | Malaca, Sara; Pesaresi, M; Kapoor, A; Berretta, P; Busardo, F P; Pirani, F | |
| Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability | 1-gen-2021 | Roberti, R.; De Caro, C.; Iannone, L. F.; Zaccara, G.; Lattanzi, S.; Russo, E. | |
| Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects | 1-gen-2020 | Brunetti, P.; Lo Faro, A. F.; Tini, A.; Busardo, F. P.; Carlier, J. | |
| Pharmacotherapeutic considerations for late-onset epilepsy | 1-gen-2020 | Brigo, Francesco; Lattanzi, Simona | |
| Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials | 1-gen-2023 | Lattanzi, Simona; Trinka, Eugen; Russo, Emilio; Del Giovane, Cinzia; Matricardi, Sara; Meletti, Stefano; Striano, Pasquale; Damavandi, Payam Tabaee; Silvestrini, Mauro; Brigo, Francesco | |
| Pharmacotoxicology of non-fentanyl derived new synthetic opioids | 1-gen-2018 | Solimini, R.; Pichini, S.; Pacifici, R.; Busardò, F. P.; Giorgetti, R. | |
| Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia | 1-gen-2024 | Richard J, Auchus; Oksana, Hamidi; Rosario, Pivonello; Irina, Bancos; Gianni, Russo; Selma F, Witchel; Andrea M, Isidori; Patrice, Rodien; Umasuthan, Srirangalingam; Florian W, Kiefer; Henrik, Falhammar; Deborah P, Merke; Nicole, Reisch; Kyriakie, Sarafoglou; Gordon B, Cutler; Julia, Sturgeon; Eiry, Roberts; Vivian H, Lin; Jean L, Chan; Robert H., Farber; Adult Trial Investigators, Cahtalyst; Giacchetti, Gilberta | |
| Phase and Orientational Behaviors in Liquid Crystalline Main-Chain/Side-Group Block Copolymers | 1-gen-1998 | D., Ferri; D., Wolff; J., Springer; Francescangeli, Oriano; M., Laus; A. S., Angeloni; G., Galli; E., Chiellini | |
| Phase and Thermal Behavior of Liquid-Crystalline Block Copolymers | 1-gen-1996 | D., Wolff; D., Ferri; J., Springer; Francescangeli, Oriano; M., Laus; A. S., Angeloni; C., Bignozzi; G., Galli; E., Chiellini | |
| Phase behavior and structural characterization of poly(1,3-propylene adipate)s with cyanoazobenzene side groups | 1-gen-1998 | E. L., Tassi; M., Paci; P. L., Magagnini; B., Yang; Francescangeli, Oriano; F., Rustichelli | |
| Phase change Ge-rich Ge–Sb–Te/Sb2Te3 core-shell nanowires by metal organic chemical vapor deposition | 1-gen-2021 | Kumar, A.; Cecchini, R.; Wiemer, C.; Mussi, V.; De Simone, S.; Calarco, R.; Scuderi, M.; Nicotra, G.; Longo, M. | |
| Phase characterization of ion-beam mixed and thermally reacted Fe/Pd thin film bilayer | 1-gen-1990 | G., Battaglin; G., Fagherazzi; S., Polizzi; G., Majni; Mengucci, Paolo | |
| Phase Composition of Al-Si Coating from the Initial State to the Hot-Stamped Condition | 1-gen-2021 | Kucera, V.; Cabibbo, M.; Prusa, F.; Fojt, J.; Petr-Soini, J.; Pilvousek, T.; Kolarikova, M.; Vojtech., D. | |
| Phase contrast microtomography of thin biomaterials | 1-gen-2004 | S., Romanzetti; E., Girardin; Rustichelli, Franco; B., Dubini; A., Snigirev; C., Raven; G., Rizzi | |
| Phase control of escapes in the fractional damped Helmholtz oscillator | 1-gen-2024 | Coccolo, Mattia; Seoane, Jesús M.; Lenci, Stefano; Sanjuán, Miguel A. F. | |
| Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies. | 1-gen-2009 | Zanardi, S.; Puntoni, M.; Maffezzini, M.; Bandelloni, R.; Mori, M.; Argusti, A.; Campodonico, F.; Turbino, L.; Branchi, D.; Montironi, Rodolfo; Decensi, A. | |
| Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours | 1-gen-2013 | G., Spitaleri; Berardi, Rossana; C., Pierantoni; T., De Pas; C., Noberasco; C., Libbra; R. González Iglesias L., Giovannoni; A., Tasciotti; D., Neri; H. D., Menssen; F., de Braud | |
| Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment | 1-gen-2012 | Mancuso, A; Di Paola, Ed; Leone, A; Catalano, Alfonso; Calabrò, F; Cerbone, L; Zivi, A; Messina, C; Alonso, S; Vigna, L; Caristo, R; Sternberg, C. N. | |
| Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study). | 1-gen-2009 | C., Pinto; F. D., Fabio; C., Barone; S., Siena; A., Falcone; Cascinu, Stefano; F. L., Rojas; G., Stella; G., Schinzari; S., Artale; V., Mutri; S., Giaquinta; L., Giannetta; A., Bardelli; A. A., Martoni | |
| Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). | 1-gen-2007 | Pinto, C; DI FABIO, F; Siena, S; Cascinu, Stefano; ROJAS LLIMPE, F; Ceccarelli, C; Mutri, V; Giannetta, L; Giaquinta, S; Funaioli, C; Berardi, Rossana; Longobardi, C; Piana, E; Martoni, A. | |
| Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) | 1-gen-2021 | Pellegrino, B.; Cavanna, L.; Boggiani, D.; Zamagni, C.; Frassoldati, A.; Schirone, A.; Caldara, A.; Rocca, A.; Gori, S.; Piacentini, F.; Berardi, R.; Brandes, A. A.; Foglietta, J.; Villa, F.; Todeschini, R.; Tognetto, M.; Naldi, N.; Bortesi, B.; Montemurro, F.; Ardizzoni, A.; Boni, L.; Musolino, A. | |
| Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma | 1-gen-2012 | Offidani, M; Polloni, C; Cavallo, F; Marina Liberati, A; Ballanti, S; Pulini, S; Catarini, M; Alesiani, F; Corvatta, L; Gentili, S; Caraffa, P; Boccadoro, M; Leoni, Pietro; Palumbo, A. | |
| Phase II study of paclitaxel in pretreated advanced gastric cancer. | 1-gen-1998 | Cascinu, Stefano; F., Graziano; N., Cardarelli; M., Marcellini; P., Giordani; E. T., Menichetti; G., Catalano | |
| Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. | 1-gen-2012 | M., Scartozzi; Loretelli, Cristian; Berardi, Rossana; C., Pierantoni; R. R., Silva; D., Mari; Giampieri, Riccardo; Faloppi, Luca; M., Pistelli; Maccaroni, Elena; Bittoni, Alessandro; M. D., Prete; E., Galizia; Cascinu, Stefano | |
| Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma. | 1-gen-2010 | F., Loupakis; G., Masi; L., Fornaro; E., Vasile; G., Allegrini; E., Fontana; C., Granetto; L., Salvatore; L., Mentuccia; M., Andreuccetti; E., Cortesi; M., Merlano; Cascinu, Stefano; A., Falcone | |
| Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy. | 1-gen-1996 | Cascinu, Stefano; E. D., Ferro; M., Ligi; F., Graziano; A., Castellani; G., Catalano | |
| Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. | 1-gen-2007 | Guarneri, V; Frassoldati, A; Ficarra, G; Puglisi, F; Andreetta, C; Michelotti, A; Cresti, N; Boni, C; Bisagni, G; Berardi, Rossana; Battelli, N; Santoro, A; Banna, G; Bottini, A; Blasio, Bd; Maiorana, A; Piacentini, F; Giovannelli, S; Jovic, G; Conte, P. | |
| Phase III dose-comparison study of Glatiramer Acetate for Multiple Sclerosis | 1-gen-2011 | Comi, G; Cohen, Jl; Arnodl, Dl; Provinciali, Leandro; On the FORTE Study Group, . . . | |
| Phase mapping of acoustic sources by beamforming and iterative far field monopole substitution | 1-gen-2012 | Castellini, P.; Sopranzetti, Francesca | |
| Phase only modulation by Polymer Dispersed Liquid Crystals | 1-gen-2002 | Lucchetta, Daniele Eugenio; R., Karapinar; A. MANNI AND F., Simoni |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 41149
- 1 Contributo su Rivista::1.1 Arti... 41149
- 4 Contributo in Atti di Convegno ... 1
- 4 Contributo in Atti di Convegno ... 1
- 7 Curatele 1
- 7 Curatele::7.1 Curatela 1
Data di pubblicazione
- In corso di stampa 20
- 2020 - 2026 11784
- 2010 - 2019 14273
- 2000 - 2009 8932
- 1990 - 1999 4489
- 1980 - 1989 1429
- 1970 - 1979 213
- 1967 - 1969 10
Editore
- Elsevier BV:PO Box 211, 1000 AE A... 309
- Elsevier Science Limited:Oxford F... 237
- Springer Verlag Germany:Tiergarte... 155
- Lippincott, Williams & Wilkins:53... 116
- Elsevier Science Incorporated / N... 98
- Taylor & Francis Limited:Rankine ... 98
- S Karger AG:Allschwilerstrasse 10... 74
- IEEE / Institute of Electrical an... 73
- John Wiley & Sons Incorporated:Cu... 62
- Kluwer Academic Publishers:Journa... 58
Rivista
- PLOS ONE 212
- CLINICAL AND EXPERIMENTAL RHEUMAT... 185
- SCIENTIFIC REPORTS 178
- LA RADIOLOGIA MEDICA 173
- ACTA HORTICULTURAE 158
- INTERNATIONAL JOURNAL OF MOLECULA... 150
- JOURNAL OF CLINICAL MEDICINE 137
- APPLIED SCIENCES 127
- SENSORS 122
- ANTIMICROBIAL AGENTS AND CHEMOTHE... 120
Serie
- ISPRS ANNALS OF THE PHOTOGRAMMETR... 1
- LECTURE NOTES IN COMPUTER SCIENCE 1
- NEUROLOGY 1
- QUADERNI DI RICERCA 1
Keyword
- Humans 2098
- Female 1064
- Male 1038
- Middle Aged 700
- Aged 636
- Adult 611
- Italy 423
- Animals 397
- COVID-19 320
- Treatment Outcome 308
Lingua
- eng 30694
- ita 3635
- fre 70
- spa 47
- ger 16
- enm 12
- por 11
- und 10
- dut 5
- chi 4
Accesso al fulltext
- no fulltext 32476
- open 6157
- reserved 1515
- partially open 944
- mixed 57
- embargoed 1